Vanda Pharmaceuticals (VNDA)
(Delayed Data from NSDQ)
$5.11 USD
+0.14 (2.82%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $5.12 +0.01 (0.20%) 6:40 PM ET
3-Hold of 5 3
C Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/01/2024
Time: -- |
3/2024 | $0.05 | 0.00% |
Earnings Summary
For their last quarter, Vanda Pharmaceuticals (VNDA) reported earnings of -$0.04 per share, beating the Zacks Consensus Estimate of $-0.09 per share. This reflects a positive earnings surprise of 55.56%. Look out for VNDA's next earnings release expected on May 01, 2024. For the next earning release, we expect the company to report earnings of $0.05 per share, reflecting a year-over-year decrease of 16.67%.
Earnings History
Price & Consensus
Zacks News for VNDA
Investors Heavily Search Vanda Pharmaceuticals Inc. (VNDA): Here is What You Need to Know
VNDA: What are Zacks experts saying now?
Zacks Private Portfolio Services